Bringing the fundamentals into focus…
Back to Protagonist Therapeutics, Inc.
How Protagonist Therapeutics, Inc. stacks up
PTGX · against 162 other Healthcare companies of similar size
Growth
83/ 100
Near the top of its peers.
Ranked #37 of 163 · scores higher than 77% of peers
Bars: peers in each 10-point band of the growth score25 peers with a growth score of 80–89, including PTGX · Click a bar to see the companies
Why growth scores 83?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth, 3-year revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
- faster growth in earnings per share: stronger than 78% of peers. Earnings per share growth: 53.2% vs peer median 9.8%
- faster revenue growth over three years: stronger than 81% of peers. 3-year revenue growth: 20.1% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 87% of peers. Revenue growth: 34.8% vs peer median 6.1%
Metric by metric
Position: dot = PTGX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PTGX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 163 reported | 34.8% | 10.2% | 83% | 33% | |
| Earnings per share growthHigher is better · 116 reported | 53.2% | 12.8% | 77% | 33% | |
| 3-year revenue growthHigher is better · 157 reported | 20.1% | 10.9% | 78% | 33% |
Ranking by growth score
Top 5 and the companies ranked around PTGX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 2 | 9.3B USD | 98 | 64 | |
| 4 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 4 | 7.3B USD | 97 | 74 | |
| 33 | 5.1B USD | 85 | 52 | |
| 35 | 4.6B USD | 84 | 65 | |
| 35 | 10.7B USD | 84 | 65 | |
| 37 | 1.26T INR (≈$15.1B) | 83 | 63 | |
| 37 | 9.1B USD | 83 | 74 | |
| 39 | 6.2B USD | 82 | 44 | |
| 39 | 6.0B USD | 82 | 30 | |
| 41 | 379.9B INR (≈$4.6B) | 81 | 55 | |
| 42 | 14.6B USD | 80 | 59 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score